Cancer is the leading cause of mortality worldwide, accounting for almost 13% of deaths in
the world. Among the conventional cancer treatments, chemotherapy is most frequently …

Thymoquinone is a monoterpenoid compound, which is derived from volatile and fixed oil of
Nigella sativa (Ranunculaceae). This phytochemical compound has several biological …

Doxorubicin (DOX) is an anthracycline drug used for cancer treatment. However, its
treatment is contiguous with toxic effects. We examined the nephroprotective potential of A …

Dual-targeted nanoparticles have been increasingly used to realize greater anti-proliferation
effect by attacking double key sites of tumor cells. In order to retain nuclei inhibition effect …

Doxorubicin (DXR) is one of the most important chemotherapeutic agent. However,
nephrotoxicity reduces its clinical utility in humans. The aim of the study was to investigate …

Dioscin shows active effects against renal ischemia/reperfusion injury and
lipopolysaccharide-induced inflammatory kidney injury, however, little is known concerning …

Nephrotoxicity is one of the limiting factors for using doxorubicin (DOX). Honey, propolis,
and royal jelly were evaluated for their ability to protect against nephrotoxicity caused by …

Piroxicam (PM) is an oxicam-NSAID commonly recommended for various pain and
associated inflammatory disorders. However, it is reported to have a gastric and hepato …

The effect of dysfunctional mitochondria in several cell pathologies has been reported in
renal diseases, including diabetic nephropathy and acute kidney injury. Previous studies …

Doxorubicin (DOX) is an anti-neoplastic therapy, but its use is limited by its deleterious toxic
effects including nephrotoxicity and cardiotoxicity. This work aimed at assessing the …